Haemonetics (HAE) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $73.64 +1.53%
EPS Growth %: -0.9%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -0.9%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.10, $0.09 better than the analyst estimate of $1.01. Revenue for the quarter came in at $321.39 million versus the consensus estimate of $302.62 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Wolfe Research upgrades Target to Top Pick, downgrades Home Depot and Five Below
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
